References
- Hughes GRV. Thrombosis, abortion, cerebral disease, and lupus anticoagulant. Br Med J 1983;287:1088–1089.
- Harris EN, Gharavi AE, Asherson RA, et al. Cerebral infarction in systemic lupus erythematosus: association with anticardiolipin antibodies. Clin Exp Rheumatol 1984;2:47–51.
- Hughes GRV, Harris EN, Gharavi AE. The anticardiolipin syndrome. J Rheumatol 1986;13:486–489.
- Derksen RHWM. Clinical manifestation and management of the antiphospholipid syndrome. Lupus 1996;5:167–169.
- Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann Intern Med 1990;112:682–698.
- Farhey Y, Hess EV. Accelerated atherosclerosis and coronary disease in SLE. Lupus 1997;6:572–577.
- George J, Shoenfeld Y. The anti-phospholipid (Hughes) syndrome: a crossroads of autoimmunity and atherosclerosis. Lupus 1997;6:559–560.
- Levine SR, Crofts JW, Lesser GR, et al. Visual symptoms associated with the presence of a lupus anticoagulant. Ophthalmology 1988;95:686–692.
- Acheson JF, Gregson RMC, Merry P, Schulenburg WE. Vaso-occlusive retinopathy in the primary antiphospholipid antibody syndrome. Eye 1991;5:48–55.
- Castaftón C, Amigo MC, Ballales IL, et al. Ocular vaso-occlusive disease in primary antiphospholi-pid syndrome. Ophthalmology 1995;102:256–262.
- Giorgi D, Vaccaro F. Vaso-occlusive retinopathy: is it a classical clinical manifestation of the antiphospholipid syndrome? [letter]. Lupus 1997;6:617.
- Asherson RA, Merry P, Acheson JF, et al. Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the 'primary' antiphospholi-pid syndrome. Ann Rheum Dis 1989;48:358–361.
- Rosove MH, Brewer PMC. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992;117:303–308.
- Derksen RHWM, de Groot PhG, Kater L, Nieuwenhuis HK. Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment. Ann Rheum Dis 1993;52:689–692.
- Rivier G, Herranz MT, Khamashta MA, Hughes GRV. Thrombosis and antiphospholipid syndrome: a preliminary assessment of three antithrombot-ic treatments. Lupus 1994;3:85–90.
- Khamashta MA, Cuadrado MJ, Mujic F, et al. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995;332:993–997.
- Landi G, Calloni MV, Sabbadini MG, et al. Recurrent ischemic attacks in two young adults with lupus anticoagulant. Stroke 1983;14:377–379.
- Gerber SL, Cantor LB. Progressive optic atrophy and the primary antiphospholipid antibody syndrome. Am J Ophthalmol 1990;11o:443–444.
- Jabs DA, Miller NR, Newman SA, et al. Optic neuropathy in systemic lupus erythematosus. Arch Ophthalmol 1986;104:564–568.
- Hughes GRV. CNS lupus. IIIrd European Conference on SLE, Pisa, Italy, 1996. Clin Exp Rheumatol 1996;14:Suppl 16.
- Rosenbaum JT, Simpson J, Neuwelt CM. Successful treatment of optic neuropathy in association with systemic lupus erythematosus using intravenous cyclophosphamide. Br J Ophthalmol 1997;81:130–132.